Preclinical investigations have demonstrated that caffeine impedes liver steatosis progression by restoring redox balance, suppressing TGF-β expression, and inhibiting hepatic stellate cell activity, whereas polyphenols exhibit antioxidative effects (23–25). Here, TGFB1 is linked to fatty liver disease.